We all know these results are going to be impressive. Ironically, unlike bigger stocks its not a case of whether they beat expectations, its whether they get picked up by the national media. I don't know, you'd think they might be at least a little interested in a company restoring upper limb function to paraplegics.....?
Further CelGro® nerve clinical trial data from all patients at 12 months, page-2
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.5¢ | $29.16K | 75.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 75123 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 37896 | 2 |
View Market Depth
| Last trade - 14.32pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
39.0¢ |
Change
-0.005 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| 38.5¢ | 39.0¢ | 38.5¢ | 25594 | ||
| Last updated 14.32pm 06/05/2024 ? | |||||
| OCC (ASX) Chart |